Follow live coverage as Norwich City face Stoke City in the Championship today. An increasingly competitive second tier in ...
Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...
Biogen (NASDAQ:BIIB) and Stoke Therapeutics (NASDAQ:STOK) said on Tuesday they are collaborating to develop and commercialize ...
Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...
A date has been set for Mohammed Farraj's full inquest after he died from a 'traumatic head injury' while working out ...
A driver reportedly attacked a police officer after trying to do a runner in Stoke-on-Trent. Officers pulled over the dark ...
The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...
Former Stoke City players have paid tribute to club legend George Eastham at a memorial service to celebrate his life.
Josh Sargent scores a second-half double to spark Norwich City to a win over Stoke City that revives their play-off hopes.
In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...
Paddy Davitt rates Johannes Hoff Thorup’s impressive Norwich City, who, as Thorup rightly asserted, were short-changed by the manner of the final scoreline against Stoke City.
Biogen and Stoke Therapeutics have signed a deal to co-develop and sell Stoke’s experimental drug for Dravet syndrome, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results